• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CAM 中经济评价的应用:介绍性框架。

The use of economic evaluation in CAM: an introductory framework.

机构信息

School of Population Health, University of Queensland, Herston Road, Herston, Queensland 4006, Australia.

出版信息

BMC Complement Altern Med. 2010 Nov 11;10:66. doi: 10.1186/1472-6882-10-66.

DOI:10.1186/1472-6882-10-66
PMID:21067622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2992473/
Abstract

BACKGROUND

For CAM to feature prominently in health care decision-making there is a need to expand the evidence-base and to further incorporate economic evaluation into research priorities.In a world of scarce health care resources and an emphasis on efficiency and clinical efficacy, CAM, as indeed do all other treatments, requires rigorous evaluation to be considered in budget decision-making.

METHODS

Economic evaluation provides the tools to measure the costs and health consequences of CAM interventions and thereby inform decision making. This article offers CAM researchers an introductory framework for understanding, undertaking and disseminating economic evaluation. The types of economic evaluation available for the study of CAM are discussed, and decision modelling is introduced as a method for economic evaluation with much potential for use in CAM. Two types of decision models are introduced, decision trees and Markov models, along with a worked example of how each method is used to examine costs and health consequences. This is followed by a discussion of how this information is used by decision makers.

CONCLUSIONS

Undoubtedly, economic evaluation methods form an important part of health care decision making. Without formal training it can seem a daunting task to consider economic evaluation, however, multidisciplinary teams provide an opportunity for health economists, CAM practitioners and other interested researchers, to work together to further develop the economic evaluation of CAM.

摘要

背景

为了使 CAM 在医疗保健决策中占据重要地位,需要扩大证据基础,并进一步将经济评估纳入研究重点。在医疗保健资源稀缺且强调效率和临床疗效的世界中,CAM(就像所有其他治疗方法一样)需要进行严格的评估,才能在预算决策中被考虑。

方法

经济评估提供了衡量 CAM 干预措施的成本和健康后果的工具,从而为决策提供信息。本文为 CAM 研究人员提供了一个理解、进行和传播经济评估的入门框架。讨论了可用于 CAM 研究的各种经济评估类型,并介绍了决策模型作为经济评估的一种方法,该方法在 CAM 中具有很大的应用潜力。引入了两种类型的决策模型,决策树和马尔可夫模型,并通过一个示例来说明如何使用每种方法来检查成本和健康后果。接下来讨论了决策者如何使用这些信息。

结论

毫无疑问,经济评估方法是医疗保健决策的重要组成部分。如果没有正式的培训,考虑经济评估可能会让人望而生畏,但是多学科团队为卫生经济学家、CAM 从业者和其他有兴趣的研究人员提供了一个机会,可以共同努力,进一步发展 CAM 的经济评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc61/2992473/f6977dca2391/1472-6882-10-66-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc61/2992473/d89c317bab1c/1472-6882-10-66-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc61/2992473/f11e9a4251ee/1472-6882-10-66-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc61/2992473/f6977dca2391/1472-6882-10-66-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc61/2992473/d89c317bab1c/1472-6882-10-66-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc61/2992473/f11e9a4251ee/1472-6882-10-66-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc61/2992473/f6977dca2391/1472-6882-10-66-3.jpg

相似文献

1
The use of economic evaluation in CAM: an introductory framework.CAM 中经济评价的应用:介绍性框架。
BMC Complement Altern Med. 2010 Nov 11;10:66. doi: 10.1186/1472-6882-10-66.
2
Square pegs and round holes? A review of economic evaluation in complementary and alternative medicine.方枘圆凿?补充和替代医学中的经济评估综述。
J Altern Complement Med. 2005 Feb;11(1):179-88. doi: 10.1089/acm.2005.11.179.
3
A research roadmap for complementary and alternative medicine - what we need to know by 2020.补充和替代医学研究路线图——到2020年我们需要了解的内容。
Forsch Komplementmed. 2014;21(2):e1-16. doi: 10.1159/000360744. Epub 2014 Mar 24.
4
Is complementary and alternative medicine (CAM) cost-effective? A systematic review.补充与替代医学(CAM)具有成本效益吗?一项系统评价。
BMC Complement Altern Med. 2005 Jun 2;5:11. doi: 10.1186/1472-6882-5-11.
5
Developing appropriate measures of the benefits of complementary and alternative medicine.
J Health Serv Res Policy. 2001 Jan;6(1):38-43. doi: 10.1258/1355819011927189.
6
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.预算影响分析良好实践原则:ISPOR良好研究实践特别工作组——预算影响分析报告
Value Health. 2007 Sep-Oct;10(5):336-47. doi: 10.1111/j.1524-4733.2007.00187.x.
7
Addressing efficiency: economic evaluation and the agenda for CAM researchers.关注效率:经济学评估与补充替代医学研究议程
Complement Ther Clin Pract. 2005 Nov;11(4):253-61. doi: 10.1016/j.ctcp.2005.04.001. Epub 2005 Jul 6.
8
Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.预算影响分析——良好实践原则:ISPOR 2012 预算影响分析良好实践 II 工作组报告。
Value Health. 2014 Jan-Feb;17(1):5-14. doi: 10.1016/j.jval.2013.08.2291. Epub 2013 Dec 13.
9
Complementary and alternative medicine costs - a systematic literature review.补充与替代医学成本——一项系统的文献综述
Forsch Komplementmed. 2006;13 Suppl 2:42-5. doi: 10.1159/000093313. Epub 2006 Jun 26.
10
Complementary medicine: equity issues in evaluation and policy-making.补充医学:评估与决策中的公平问题。
Forsch Komplementmed. 2007 Dec;14 Suppl 2:2-9. doi: 10.1159/000112202. Epub 2008 Jan 7.

本文引用的文献

1
Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada.利用有效性和成本效益来做出药物覆盖范围决策:英国、澳大利亚和加拿大的比较
JAMA. 2009 Oct 7;302(13):1437-43. doi: 10.1001/jama.2009.1409.
2
How do government health departments in Australia access health economics advice to inform decisions for health? A survey.澳大利亚政府卫生部门如何获取卫生经济学建议以指导卫生决策?一项调查。
Aust New Zealand Health Policy. 2009 Apr 9;6:6. doi: 10.1186/1743-8462-6-6.
3
Utilising and promoting public health and health services research in complementary and alternative medicine: the founding of NORPHCAM.
利用并推广补充与替代医学领域的公共卫生及卫生服务研究:北欧补充与替代医学研究中心的成立
Complement Ther Med. 2008 Oct;16(5):245-6. doi: 10.1016/j.ctim.2008.08.002.
4
Utility estimates for decision-analytic modeling in chronic heart failure--health states based on New York Heart Association classes and number of rehospitalizations.慢性心力衰竭决策分析模型的效用估计——基于纽约心脏协会分级和再住院次数的健康状态
Value Health. 2009 Jan-Feb;12(1):185-7. doi: 10.1111/j.1524-4733.2008.00425.x. Epub 2008 Jul 18.
5
Review of Australian health economic evaluation - 245 interventions: what can we say about cost effectiveness?澳大利亚卫生经济评价回顾 - 245 项干预措施:关于成本效果,我们能说些什么?
Cost Eff Resour Alloc. 2008 May 20;6:9. doi: 10.1186/1478-7547-6-9.
6
How much are Americans willing to pay for a quality-adjusted life year?美国人愿意为一个质量调整生命年支付多少钱?
Med Care. 2008 Apr;46(4):343-5. doi: 10.1097/MLR.0b013e31816a7144.
7
Health technology assessment in Australia: challenges ahead.
Med J Aust. 2007 Sep 3;187(5):262-4. doi: 10.5694/j.1326-5377.2007.tb01238.x.
8
Auditing outcomes and costs of integrated complementary medicine provision--the importance of length of follow up.综合补充医学服务的审计结果与成本——随访时长的重要性
Complement Ther Clin Pract. 2006 Nov;12(4):249-57. doi: 10.1016/j.ctcp.2006.07.007. Epub 2006 Sep 27.
9
Whither trial-based economic evaluation for health care decision making?基于试验的卫生保健决策经济评估何去何从?
Health Econ. 2006 Jul;15(7):677-87. doi: 10.1002/hec.1093.
10
Complementary or alternative medicine: towards establishing 'value for money'.
Complement Ther Med. 2006 Mar;14(1):1-2. doi: 10.1016/j.ctim.2006.01.002. Epub 2006 Jan 31.